Chung Hwa Bio: March 2026 Revenue Reaches 131 Million (Up 108.9% Year-on-Year)
Chung Hwa Bio (stock code: 1762) announced its March 2026 monthly revenue of 131.435 million JPY, a significant 108.9% increase compared to the same period last year. This strong performance highlights the company's robust growth within the biotechnology and medical sector.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
- 🤖 AI Analyzed: April 12, 2026 at 17:27 (57 min after Collected)
Company Code: 1762
Company Name: Chung Hwa Bio
Industry: Biotechnology and Medical
Data Month: 2026-03
Monthly Revenue: 131,435 thousand JPY (131 million JPY)
Year-on-Year Change: +108.9%
Company Name: Chung Hwa Bio
Industry: Biotechnology and Medical
Data Month: 2026-03
Monthly Revenue: 131,435 thousand JPY (131 million JPY)
Year-on-Year Change: +108.9%
FAQ
What was Chung Hwa Bio's revenue in March 2026?
Chung Hwa Bio's monthly revenue in March 2026 was 131,435,000 JPY (131.435 million JPY).
How much did the revenue increase compared to the same month last year?
It increased by 108.9% compared to the same month last year.
What kind of business does Chung Hwa Bio operate in?
Chung Hwa Bio operates in the biotechnology and medical industry.